From the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China; and China National Clinical Research Center for Neurological Diseases, Beijing.
Stroke. 2019 Dec;50(12):3532-3539. doi: 10.1161/STROKEAHA.119.026872. Epub 2019 Oct 10.
Background and Purpose- Stroke and Alzheimer disease are 2 major causes of neurological disability in aged people and shared overlapping predictors. In recent prospective studies, high Lp(a) [lipoprotein(a)] level is associated with high risk of stroke but low risk of Alzheimer disease. Whether this reflects a causal association remains to be established. The aim of this study is to examine the causal associations of Lp(a) concentrations on ischemic stroke, ischemic stroke subtypes, and Alzheimer disease. Methods- We used 9 single-nucleotide polymorphisms associated with Lp(a) concentrations as instrumental variables. Summary-level data on ischemic stroke and its subtypes were obtained from the Multiancestry Genome-Wide Association Study of Stroke consortium with European individuals ≤446 696 individuals. Summary-level data on Alzheimer disease were obtained from the International Genomics of Alzheimer Project With European individuals ≤54 162 individuals. Two-sample Mendelian randomization (MR) estimates were calculated with inverse-variance weighted, penalized inverse-variance weighted, simple median, weighted median, and MR Pleiotropy Residual Sum and Outlier approaches, and MR-Egger regression was used to explore pleiotropy. Results- Genetically predicted 1-SD log-transformed increase in Lp(a) concentrations was associated with a substantial increase in risk of large artery stroke (odds ratio, 1.20; 95% CI, 1.11-1.30; <0.001) and a reduce in risk of small vessel stroke (odds ratio, 0.92; 95% CI, 0.88-0.97; =0.001) and Alzheimer disease (odds ratio, 0.94; 95% CI, 0.91-0.97; <0.001) using inverse-variance weighted method. No significant association was observed for total ischemic stroke or cardioembolic stroke. MR-Egger indicated no evidence of pleiotropic bias. Results were broadly consistent in sensitivity analyses using penalized inverse-variance weighted, simple median, weighted median, and MR Pleiotropy Residual Sum and Outlier approaches accounting for potential genetic pleiotropy or outliers. Conclusions- This study provides evidence to support that high Lp(a) concentrations was causally associated with an increased risk of large artery stroke but a decreased risk of small vessel stroke and Alzheimer disease. The mechanism underlying the double-edged sword effect of Lp(a) concentrations on neurological system requires further investigation.
背景与目的- 中风和阿尔茨海默病是老年人中两种主要的神经功能障碍原因,并且具有重叠的共同预测因素。在最近的前瞻性研究中,高脂蛋白(a)[脂蛋白(a)]水平与中风风险增加但阿尔茨海默病风险降低有关。这是否反映了因果关系仍有待确定。本研究旨在检验脂蛋白(a)浓度对缺血性中风、缺血性中风亚型和阿尔茨海默病的因果关系。
方法- 我们使用 9 个与脂蛋白(a)浓度相关的单核苷酸多态性作为工具变量。缺血性中风及其亚型的汇总水平数据来自中风多民族全基因组关联研究联盟,其中包含≤446696 名欧洲个体。阿尔茨海默病的汇总水平数据来自欧洲个体≤54162 名的国际阿尔茨海默病基因组学项目。使用逆方差加权、惩罚逆方差加权、简单中位数、加权中位数和 MR 偏倚残差和异常值方法计算两样本孟德尔随机化(MR)估计值,并使用 MR-Egger 回归探索偏倚。
结果- 遗传预测的 1-SD 对数转换脂蛋白(a)浓度增加与大动脉中风风险显著增加相关(优势比,1.20;95%置信区间,1.11-1.30;<0.001),小血管中风风险降低相关(优势比,0.92;95%置信区间,0.88-0.97;=0.001)和阿尔茨海默病(优势比,0.94;95%置信区间,0.91-0.97;<0.001),使用逆方差加权法。总缺血性中风或心源性栓塞性中风未见显著相关性。MR-Egger 表明没有证据表明存在偏倚。使用惩罚逆方差加权、简单中位数、加权中位数和 MR 偏倚残差和异常值方法进行敏感性分析,考虑到潜在的遗传偏倚或异常值,结果基本一致。
结论- 本研究提供了证据支持高脂蛋白(a)浓度与大动脉中风风险增加但小血管中风和阿尔茨海默病风险降低有关。脂蛋白(a)浓度对神经系统的双刃剑效应的潜在机制需要进一步研究。